Avacta Group PLC (AVCT)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

45.50p

Buy

46.00p

arrow-down-1.027p (-2.20%)

Prices updated at 02 May 2024, 13:35 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Avacta Group PLC is a United Kingdom based company, which caters to the healthcare sector. It develops medical diagnostic products such as reagents and arrays which are helpful in drug discovery.
FTSE All-Share
arrow-up0.43%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Dr. Eliot Richard Forster, M.B.A.,PhD
CEO
Dr. Christina Marie Coughlin
Most recent earnings
31 Dec 2022
Fiscal year end
31 Dec 2022
Employees
113
Head office
Unit 20, Ash Way
Wetherby
United Kingdom
LS23 7FA
mobile
+44 1904217070
letter
investors@avacta.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Dr. Eliot Richard Forster, M.B.A.,PhD
Non-Executive Director, Chairman
-
Dr. Trevor John Nicholls
Non-Executive Director
-
Mr. Shaun Edward Chilton
Non-Executive Director
-
Mr. Paul Andrew Fry
Non-Executive Director
-
Mr. Tony Peter Gardiner
Executive Director, Chief Financial Officer and Company Secretary
-
Dr. Christina Marie Coughlin
Executive Director, Chief Executive Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Baillie Gifford & Co Limited.6,166,767
Unicorn Asset Management Ltd4,300,000
Unicorn AIM VCT Series 3 ORD4,300,000
Edinburgh Worldwide3,417,487
AXA Investment Managers UK Ltd2,336,248

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
04 Mar 2024Purchase
04 Mar 2024Purchase
04 Mar 2024Purchase
04 Mar 2024Purchase
Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.